CALC Stock Analysis: Buy, Sell, or Hold?
CALC - CalciMedica, Inc. Common Stock
$0.90
-0.12 (-11.76%)
▼
WAIT
LOW Confidence
Last Updated: January 30, 2026
Get Alerted When CALC Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: CALC is down 82.9% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: CALC is down 82.9% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: CALC is currently trading at $0.90, which is considered oversold relative to its 30-day fair value range of $3.68 to $6.73.
Technical Outlook: Technically, CALC is in a uptrend. Immediate support is located at $0.82, while resistance sits at $5.95. Short-term momentum is weak, with the stock down 11.8% recently.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $16.25 (+1493.1%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, CALC is in a uptrend. Immediate support is located at $0.82, while resistance sits at $5.95. Short-term momentum is weak, with the stock down 11.8% recently.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $16.25 (+1493.1%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Fair Price Range
$3.68 -
$6.73
Company Quality Score
38/100
(SELL)
Volume Confirmation
MODERATE
Confidence Score
72.1%
Protect Your Profits
Holding CALC? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (55/100)
- BEARISH: Downward momentum (-11.8%)
- BULLISH: Trading 1493.1% below Wall St target ($16.25)
- WARNING: Recommendation downgraded due to -82.9% 5-day decline - wait for stabilization
Fair Price Analysis
30-Day Fair Range
$3.68 -
$6.73
Current vs Fair Value
OVERSOLD
Support & Resistance Levels
Support Level
$0.82
Resistance Level
$5.95
Current Trend
Uptrend
Fundamental Context
Forward P/E (Next Year Est.)
-0.63
Wall Street Target
$16.25
(+1493.1%)
Last updated: January 30, 2026 5:36 PM ET
Data refreshes hourly during market hours. Next update: 6:36 PM
Data refreshes hourly during market hours. Next update: 6:36 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CALC showing a specific setup today?
Insider Activity (6 Months)
13
Buys
0
Sells
+
Net
INSIDERS BUYING
Recent Transactions
Eric W Roberts
BUY
2500 shares
2025-09-18
Eric W Roberts
BUY
3400 shares
2025-09-15
Eric W Roberts
BUY
5000 shares
2025-09-12
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ACLX
Arcellx Inc |
STRONG BUY
18 analysts |
$112 | 52 HOLD |
|
BBIO
BridgeBio Pharma Inc |
STRONG BUY
19 analysts |
$90 | 59 HOLD |
|
RNA
Avidity Biosciences Inc |
STRONG BUY
15 analysts |
$75 | 62 BUY |
|
GPCR
Structure Therapeutics I… |
STRONG BUY
14 analysts |
$108 | 56 HOLD |
|
APLS
Apellis Pharmaceuticals … |
BUY
22 analysts |
$35 | 51 HOLD |
Advanced CALC Option Strategies
Professional options setups generated by AI based on today's CALC price and gamma walls.
